153 related articles for article (PubMed ID: 38010520)
1. Liver fibrosis and outcomes of atrial fibrillation: the FIB-4 index.
Raposeiras-Roubín S; Parada Barcia JA; Lizancos Castro A; Noriega Caro V; Ledo Piñeiro A; González Bermúdez I; González Ferreiro R; Íñiguez-Romo A; Abu-Assi E
Clin Res Cardiol; 2024 Feb; 113(2):313-323. PubMed ID: 38010520
[TBL] [Abstract][Full Text] [Related]
2. Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants.
Pastori D; Lip GYH; Farcomeni A; Del Sole F; Sciacqua A; Perticone F; Marcucci R; Grifoni E; Pignatelli P; Violi F;
Int J Cardiol; 2018 Aug; 264():58-63. PubMed ID: 29776574
[TBL] [Abstract][Full Text] [Related]
3. Liver Fibrosis-4 index indicates atrial fibrillation in acute ischemic stroke.
Fandler-Höfler S; Kneihsl M; Stauber RE; Bisping E; Mangge H; Wünsch G; Haidegger M; Fabisch L; Hatab I; Fickert P; Werring D; Enzinger C; Gattringer T
Eur J Neurol; 2022 Aug; 29(8):2283-2288. PubMed ID: 35485970
[TBL] [Abstract][Full Text] [Related]
4. Liver fibrosis scores and atrial fibrillation incidence in heart failure with preserved ejection fraction.
Liu X; Chen W; Shao W; Jiang Y; Cao Z; He W; Wu M; Chen Z; Ma J; Chen Y; Yu P; Zhang Y; Wang J
ESC Heart Fail; 2022 Dec; 9(6):3985-3994. PubMed ID: 35996808
[TBL] [Abstract][Full Text] [Related]
5. FIB-4 index and liver fibrosis are risk factors for long-term outcomes in atrial fibrillation-related stroke.
Kim TH; Kim SY; Jung YK; Yim HJ; Jung JM; Seo WK
Clin Neurol Neurosurg; 2022 Jun; 217():107235. PubMed ID: 35429852
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes in elderly atrial fibrillation patients at increased bleeding risk treated with very low dose vs. regular-dose non-vitamin K antagonist oral anticoagulants: a nationwide cohort study.
Chan YH; Chao TF; Chen SW; Lee HF; Li PR; Yeh YH; Kuo CT; See LC; Lip GYH
Eur Heart J Cardiovasc Pharmacother; 2023 Dec; 9(8):681-691. PubMed ID: 37580139
[TBL] [Abstract][Full Text] [Related]
7. Fibrosis-4 index is closely associated with clinical outcomes in acute cardioembolic stroke patients with nonvalvular atrial fibrillation.
Yang L; Gao K; Shi RJ; Qin YN; Huang XR; Gao YJ; Zheng XP
Intern Emerg Med; 2023 Nov; 18(8):2209-2222. PubMed ID: 37891451
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of patients with atrial fibrillation on oral anticoagulation with and without heart failure: the ETNA-AF-Europe registry.
Schnabel RB; Ameri P; Siller-Matula JM; Diemberger I; Gwechenberger M; Pecen L; Manu MC; Souza J; De Caterina R; Kirchhof P
Europace; 2023 Aug; 25(9):. PubMed ID: 37713182
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of liver fibrosis assessed by the FIB-4 index in patients with acute coronary syndrome.
Cordero A; Escribano D; Quintanilla MA; López-Ayala JM; Masiá MD; Cazorla D; Martínez Rey-Rañal E; Moreno-Arribas J; Zuazola P
Rev Esp Cardiol (Engl Ed); 2023 Aug; 76(8):618-625. PubMed ID: 36669734
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
[TBL] [Abstract][Full Text] [Related]
11. ISCHEMIC STROKE AND MAJOR BLEEDING WHILE ON DIRECT ORAL ANTICOAGULANTS IN NAÏVE PATIENTS WITH ATRIAL FIBRILLATION: IMPACT OF RESUMPTION OR DISCONTINUATION OF ANTICOAGULANT TREATMENT. A population-based study.
Gennaro N; Ferroni E; Zorzi M; Denas G; Pengo V
Int J Cardiol; 2024 Jan; 394():131369. PubMed ID: 37722453
[TBL] [Abstract][Full Text] [Related]
12. Association of Body Mass Index With Clinical Outcomes in Patients With Atrial Fibrillation: A Report From the FANTASIIA Registry.
Bertomeu-Gonzalez V; Moreno-Arribas J; Esteve-Pastor MA; Roldán-Rabadán I; Muñiz J; Raña-Míguez P; Ruiz-Ortiz M; Cequier Á; Bertomeu-Martínez V; Badimón L; Anguita M; Lip GYH; Marín F;
J Am Heart Assoc; 2020 Jan; 9(1):e013789. PubMed ID: 31870235
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular and renal outcomes in patients with atrial fibrillation and stage 4-5 chronic kidney disease receiving direct oral anticoagulants: a multicenter retrospective cohort study.
Lin Y; Chao TF; Tsai ML; Tseng CJ; Wang TH; Chang CH; Lin YS; Yang NI; Chu PH; Hung MJ; Wu VC; Chen TH
J Thromb Thrombolysis; 2024 Jan; 57(1):89-100. PubMed ID: 37605063
[TBL] [Abstract][Full Text] [Related]
14. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.
Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA
JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848
[TBL] [Abstract][Full Text] [Related]
15. Predicting Adverse Events beyond Stroke and Bleeding with the ABC-Stroke and ABC-Bleeding Scores in Patients with Atrial Fibrillation: The Murcia AF Project.
Camelo-Castillo A; Rivera-Caravaca JM; Marín F; Vicente V; Lip GYH; Roldán V
Thromb Haemost; 2020 Aug; 120(8):1200-1207. PubMed ID: 32506417
[TBL] [Abstract][Full Text] [Related]
16. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
[TBL] [Abstract][Full Text] [Related]
17. Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk.
Chao TF; Chan YH; Chiang CE; Tuan TC; Liao JN; Chen TJ; Lip GYH; Chen SA
Eur Heart J Qual Care Clin Outcomes; 2022 Oct; 8(7):730-738. PubMed ID: 34694379
[TBL] [Abstract][Full Text] [Related]
18. Direct Oral Anticoagulants versus Vitamin K Antagonists in Cirrhotic Patients with Atrial Fibrillation: Update of Systematic Review and Meta-Analysis.
Hu T; Li YH; Han WQ; Maduray K; Chen TS; Hao L; Zhong JQ
Am J Cardiovasc Drugs; 2023 Nov; 23(6):683-694. PubMed ID: 37639201
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of impaired hepato-renal function and liver fibrosis in patients admitted for acute heart failure.
Kawahira M; Tamaki S; Yamada T; Watanabe T; Morita T; Furukawa Y; Kawasaki M; Kikuchi A; Kawai T; Seo M; Nakamura J; Kayama K; Kimura T; Ueda K; Sakamoto D; Kogame T; Ito S; Chang Y; Fukunami M
ESC Heart Fail; 2021 Apr; 8(2):1274-1283. PubMed ID: 33472273
[TBL] [Abstract][Full Text] [Related]
20. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
